FY26 audited results, dividend, office shift to Maharashtra, renewable energy deal
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shilpa Medicare FY26 standalone: total income Rs 63,517 lakhs vs 54,708; net profit Rs 13,297 lakhs vs 6,594 (over 2x). EPS Rs 6.80 vs 3.48. Final dividend of Rs 0.60 per share declared. Auditors gave unmodified opinion. Subsidiaries to invest 28 percent in Neo Green Power for captive renewable energy. Board approved shifting registered office from Karnataka to Maharashtra via postal ballot. Prior year figures restated for business combination.
Strong earnings growth and dividend are positive for shareholders. Office shift and energy investment are operational moves, no material risk signalled.